PubMed Health⌕ Search

Biomedical subjects

David S Hage

Publications and source records attributed to David S Hage.

26 records · Page 2Linked to original sources
PubMed2004

Development and evaluation of N-hydroxysuccinimide-activated silica for immobilizing human serum albumin in liquid chromatography columns.

A method was developed for preparing N-hydroxysuccinimide (NHS)-activated silica for use in immobilizing human serum albumin (HSA) within HPLC columns. This support was made by reacting aminopropyl silica with disuccinimidyl suberate (DSS). Solid state 13C NMR was used to examine the steps in this synthesis. The number of NHS groups on the silica's surface was controlled by varying the amount of DSS or density of surface amine groups used in the preparing this material. Items considered in the use of this material for the immobilization of HSA included the amount of protein added to the support, the reaction time, and the pH of the coupling buffer. These supports were then evaluated in terms of their ability to perform chiral separations for R/S-warfarin and D/L-tryptophan. Advantages of this method compared to current immobilization techniques for HSA included its better long-term stability and the fact that it did not require the use of any reducing agents. The approaches developed in this work are not limited to HSA but can be used with other proteins or amine-containing ligands.

Chromatography, High Pressure Liquid↗
PubMed2004

Characterization of drug interactions with soluble beta-cyclodextrin by high-performance affinity chromatography.

This study examined the use of an immobilized human serum albumin (HSA) column to study solution-phase reactions between drugs and beta-cyclodextrin (beta-CD). Chromatographic equations were developed to characterize the binding of chemicals to a soluble ligand (beta-CD) in the presence of an independent immobilized ligand (HSA). Situations considered included the presence of both a homogeneous and heterogeneous immobilized ligand, as well as complex interactions between the chemical of interest and soluble ligand. Three drugs (warfarin, tamoxifen, and phenytoin) were examined by this approach. This method involved injecting a small amount of each drug onto an HSA column in the presence of various concentrations of beta-CD in the mobile phase. By measuring the change in the drug's retention factor as the concentration of beta-CD was varied, it was possible to determine the stability constant between the injected drug and beta-CD. With this approach, warfarin and beta-CD were found to have 1:1 interactions with a stability constant of 5.2 x 10(2) M(-1) at 37 degrees C and pH 7.4, a result in close agreement with previous literature values. Tamoxifen and phenytoin were also found to have 1:1 interactions with beta-CD and had stability constants of 0.9-1.2 x 10(4) and 6-9 x 10(2) M(-1) respectively. With these latter solutes, the effects of secondary binding to the chromatographic support had to be considered. The theory and methods described in this report are not limited to these drugs and beta-CD but can be applied to other analytes and soluble ligands.

Chromatography, Affinity↗
PubMed2004

Development of a portable immunoextraction-reversed-phase liquid chromatography system for field studies of herbicide residues.

A portable system based on immunoextraction and reversed-phase HPLC was developed for the field analysis of herbicides in groundwater and surface water. Atrazine, simazine, and cyanazine were used as model analytes for this work. These were measured in water by using three coupled columns: an anti-atrazine antibody column for the selective extraction of these analytes, a reversed-phase precolumn for their reconcentration, and a reversed-phase analytical column for their separation. Various factors were considered in the optimization of this system, including the binding properties of the immunoextraction column, the effect of flow rate on the performance of each column, the selection of sample volume, and the choice of mobile phases for the RPLC columns. A typical analysis with this system allowed the injection of one sample every 7.5 min and provided results for all three of the tested herbicides in less than 10 min. In the analysis of atrazine alone, samples could be injected every 4 min and results were obtained within 8 min. There was good correlation between this technique and a comparable benchtop system. The lower limits of detection for the given analytes were approximately 0.2-0.25 microg/L, with a linear range that extended to 20 microg/L and a dynamic range that went up to at least 100 microg/L. The use of this technique in the field was demonstrated through applications that involved the development of time and location profiles for triazine herbicides in environmental samples.

Acetonitriles↗
PubMed2004

Screening major binding sites on human serum albumin by affinity capillary electrophoresis.

A screening method is described for determining whether a drug or small solute has significant interactions at the two major binding sites on human serum albumin (HSA). This method uses affinity capillary electrophoresis (ACE) to perform a mobility shift assay, where the solute of interest is injected in both the presence of pH 7.4, 0.067 M phosphate buffer, and the same buffer containing a known concentration of HSA. Dextran is also used in the running buffer to adjust the mobility of HSA. Two types of modified HSA are used in this assay. The first is modified with 2-hydroxy-5-nitrobenzyl bromide (HNB), which selectively blocks HSA's warfarin-azapropazone site. The second type of HSA is modified with tetranitromethane (TNM), which decreases binding at the indole-benzodiazepine site. By comparing the mobility of a solute in the presence of these two modified forms of HSA vs normal HSA, it is possible to detect solute interactions at these binding sites. This approach is illustrated using warfarin and ibuprofen as examples of test solutes.

2-Hydroxy-5-nitrobenzyl Bromide↗
PubMed2002

High-performance affinity chromatography: a powerful tool for studying serum protein binding.

High-performance affinity chromatography (HPAC) is a method in which a biologically-related ligand is used as a stationary phase in an HPLC system. This approach is a powerful means for selectively isolating or quantitating agents in complex samples, but it can also be employed to study the interactions of biological systems. In recent years there have been numerous reports in which HPAC has been used to examine the interactions of drugs, hormones and other substances with serum proteins. This review discusses how HPAC has been used in such work. Particular attention is given to the techniques of zonal elution and frontal analysis. Various applications are provided for these techniques, along with a list of factors that need to be considered in their optimization and use. New approaches based on band-broadening studies and rapid immunoextraction are also discussed.

Blood Proteins↗
PubMed2002

Identification of drug-binding sites on human serum albumin using affinity capillary electrophoresis and chemically modified proteins as buffer additives.

A technique based on affinity capillary electrophoresis (ACE) and chemically modified proteins was used to screen the binding sites of various drugs on human serum albumin (HSA). This involved using HSA as a buffer additive, following the site-selective modification of this protein at two residues (tryptophan 214 or tyrosine 411) located in its major binding regions. The migration times of four compounds (warfarin, ibuprofen, suprofen and flurbiprofen) were measured in the presence of normal or modified HSA. These times were then compared and the mobility shifts observed with the modified proteins were used to identify the binding regions of each injected solute on HSA. Items considered in optimizing this assay included the concentration of protein placed into the running buffer, the reagents used to modify HSA, and the use of dextran as a secondary additive to adjust protein mobility. The results of this method showed good agreement with those of previous reports. The advantages and disadvantages of this approach are examined, as well as its possible extension to other solutes.

2-Hydroxy-5-nitrobenzyl Bromide↗
PubMedDate not supplied

Chromatographic competitive binding immunoassays: a comparison of the sequential and simultaneous injection methods.

Two approaches for performing competitive binding immunoassays by HPLC and other flow-based systems are the simultaneous and sequential injection methods. Both these techniques make use of a column with a limited amount of antibody, onto which is injected a sample and a fixed amount of a labeled analyte analog. An indirect measure of the unlabeled analyte in the sample is then obtained by looking at the amount of analog in either the nonretained or retained peaks. In the simultaneous injection mode, the sample and labeled analog are applied at the same time to the column, while in the sequential mode the sample is injected first, followed by the analog. This results in a difference in the analytical characteristics of these two approaches. This study used chromatographic theory and previous data obtained for injections of human serum albumin (HSA) onto an anti-HSA antibody column to compare the response, detection limits, range, and sensitivity of these methods. Under equivalent conditions, it was found that the sequential method always provided the best lower limit of detection and sensitivity. However, the simultaneous mode had a broader dynamic range and higher upper limit of detection. From these observations, several guidelines were developed regarding the use and selection of such assays for new applications.

Binding, Competitive↗